Table of contents
Volume 80, Issue 1-2
Published online 26 March 1999 (1-313)
Regular Articles
Retinoids: present role and future potential FREE
T R J Evans and S B Kaye
Br J Cancer 80: 1-8; doi:10.1038/sj.bjc.6690312
Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome FREE
E C Burt, G McGown, M Thorncroft, L A James, J M Birch and J M Varley
Br J Cancer 80: 9-10; doi:10.1038/sj.bjc.6690313
Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours FREE
C Ghimenti, P Tannergård, S Wahlberg, T Liu, P G Giulianotti, F Mosca, G Fornaciari, G Bevilacqua, A Lindblom and M A Caligo
Br J Cancer 80: 11-16; doi:10.1038/sj.bjc.6690314
A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation FREE
I Fajardo, A R Quesada, I Núñez de Castro, F Sánchez-Jiménez and M Á Medina
Br J Cancer 80: 17-24; doi:10.1038/sj.bjc.6690315
Generation of reactive oxygen species by human mesothelioma cells FREE
K Kahlos, S Pitkänen, I Hassinen, K Linnainmaa and V L Kinnula
Br J Cancer 80: 25-31; doi:10.1038/sj.bjc.6690316
Glutathione-linked enzymes in benign and malignant oesophageal tissue FREE
R D Levy, M M J Oosthuizen, E Degiannis, D Greyling and C Hatzitheofilou
Br J Cancer 80: 32-37; doi:10.1038/sj.bjc.6690317
In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases FREE
A G Emanuels, J Koudstaal, M P M Burger and H Hollema
Br J Cancer 80: 38-43; doi:10.1038/sj.bjc.6690318
Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours FREE
W E Farrell, D J Simpson, J Bicknell, J L Magnay, E Kyrodimou, R V Thakker and R N Clayton
Br J Cancer 80: 44-50; doi:10.1038/sj.bjc.6690319
DCC expression is related to mucinous differentiation but not changes in expression of p21WAF1/Cip1 and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas FREE
M Saegusa and I Okayasu
Br J Cancer 80: 51-58; doi:10.1038/sj.bjc.6690320
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations FREE
A Rashid, J-S Wang, G-S Qian, B-X Lu, S R Hamilton and J D Groopman
Br J Cancer 80: 59-66; doi:10.1038/sj.bjc.6690321
Short communication
The human herpesvirus-type 8 is not involved in malignant melanoma FREE
M Deichmann, M Thome, M Bock, A Jäckel, V Waldmann and H Näher
Br J Cancer 80: 67-69; doi:10.1038/sj.bjc.6690322
Regular Articles
Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours FREE
Z-J Wang, M Churchman, I G Campbell, W-H Xu, Z-Y Yan, W G McCluggage, W D Foulkes and I P M Tomlinson
Br J Cancer 80: 70-72; doi:10.1038/sj.bjc.6690323
Different gene expression of MDM2, GAGE-1, –2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia FREE
T Schlott, K Ahrens, I Ruschenburg, S Reimer, H Hartmann and M Droese
Br J Cancer 80: 73-78; doi:10.1038/sj.bjc.6690324
Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines FREE
M Sartor, H Steingrimsdottir, F Elamin, J Gäken, S Warnakulasuriya, M Partridge, N Thakker, N W Johnson and M Tavassoli
Br J Cancer 80: 79-86; doi:10.1038/sj.bjc.6690505
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity FREE
J-L D Klein, J D Roberts, M D George, J Kurtzberg, P Breton, J-C Chermann and K Olden
Br J Cancer 80: 87-95; doi:10.1038/sj.bjc.6690326
Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice FREE
Y Honma, Y Yamamoto-Yamaguchi and Y Kanatani
Br J Cancer 80: 96-103; doi:10.1038/sj.bjc.6690327
Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia FREE
M J Allalunis-Turner, A J Franko and M B Parliament
Br J Cancer 80: 104-109; doi:10.1038/sj.bjc.6690328
Anti-tumour promoter activity in Malaysian ginger rhizobia used in traditional medicine FREE
S Vimala, A W Norhanom and M Yadav
Br J Cancer 80: 110-116; doi:10.1038/sj.bjc.6690329
The effects of hyperoxic and hypercarbic gases on tumour blood flow FREE
T J Dunn, R D Braun, W E Rhemus, G L Rosner, T W Secomb, G M Tozer, D J Chaplin and M W Dewhirst
Br J Cancer 80: 117-126; doi:10.1038/sj.bjc.6690330
Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells FREE
K Takenaga
Br J Cancer 80: 127-132; doi:10.1038/sj.bjc.6690331
Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy FREE
M Nishiwaki, Y Fujise, T O Yoshida, E Matsuzawa and Y Nishiwaki
Br J Cancer 80: 133-141; doi:10.1038/sj.bjc.6690332
Effects of radiotherapy and estramustine on the microvasculature in malignant glioma FREE
M Johansson, A T Bergenheim, A Widmark and R Henriksson
Br J Cancer 80: 142-148; doi:10.1038/sj.bjc.6690333
Characterization of the model for experimental testicular teratoma in 129/SvJ-mice FREE
J Sundström, L J Pelliniemi, T Kuopio, E Veräjänkorva, K Fröjdman, V Harley, E Salminen and P Pöllänen
Br J Cancer 80: 149-160; doi:10.1038/sj.bjc.6690334
Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats FREE
J H W de Wilt, E R Manusama, S T van Tiel, M G A van Ijken, T L M ten Hagen and A M M Eggermont
Br J Cancer 80: 161-166; doi:10.1038/sj.bjc.6690335
Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors FREE
T Jahkola, T Toivonen, K von Smitten, I Virtanen, V-M Wasenius and C Blomqvist
Br J Cancer 80: 167-174; doi:10.1038/sj.bjc.6690336
Radioimmunotherapy of micrometastases in lung with vascular targeted213Bi FREE
S J Kennel, R Boll, M Stabin, H M Schuller and S Mirzadeh
Br J Cancer 80: 175-184; doi:10.1038/sj.bjc.6690337
Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study FREE
N Lange, P Jichlinski, M Zellweger, M Forrer, A Marti, L Guillou, P Kucera, G Wagnières and H van den Bergh
Br J Cancer 80: 185-193; doi:10.1038/sj.bjc.6690338
Down-regulation of TGF-
receptors in human colorectal cancer: implications for cancer development FREE
M Matsushita, K Matsuzaki, M Date, T Watanabe, K Shibano, T Nakagawa, S Yanagitani, Y Amoh, H Takemoto, N Ogata, C Yamamoto, Y Kubota, T Seki, H Inokuchi, M Nishizawa, H Takada, T Sawamura, A Okamura and K Inoue
Br J Cancer 80: 194-205; doi:10.1038/sj.bjc.6690339
Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization FREE
S-Y Jiang, S-R Shen, R-Y Shyu, J-C Yu, H-J Harn, M-Y Yeh, M M-S Lee and Y-C Chang
Br J Cancer 80: 206-214; doi:10.1038/sj.bjc.6690340
The hospital costs of treating lung cancer in the United Kingdom FREE
J L Wolstenholme and D K Whynes
Br J Cancer 80: 215-218; doi:10.1038/sj.bjc.6690341
Seroconversion after influenza vaccination in patients with lung cancer FREE
H Anderson, K Petrie, C Berrisford, A Charlett, N Thatcher and M Zambon
Br J Cancer 80: 219-220; doi:10.1038/sj.bjc.6690342
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion FREE
J Vinholes, R Coleman, D Lacombe, C Rose, M Tubiana-Hulin, P Bastit, J Wildiers, J Michel, R Leonard, J Nortier, F Mignolet and J Ford
Br J Cancer 80: 221-228; doi:10.1038/sj.bjc.6690506
Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response FREE
E Reyes, I García-Castro, F Esquivel, J Hornedo, H Cortes-Funes, J Solovera and M Alvarez-Mon
Br J Cancer 80: 229-235; doi:10.1038/sj.bjc.6690344
Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas FREE
K Kohshi, Y Kinoshita, H Imada, N Kunugita, H Abe, H Terashima, N Tokui and S Uemura
Br J Cancer 80: 236-241; doi:10.1038/sj.bjc.6690345
Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking FREE
R Brown, P N Butow, M J Boyer and M H N Tattersall
Br J Cancer 80: 242-248; doi:10.1038/sj.bjc.6690346
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection FREE
K D Jacobsen, S Ous, H Wæhre, H Trasti, A E Stenwig, H H Lien, N Aass and S D Fosså
Br J Cancer 80: 249-255; doi:10.1038/sj.bjc.6690347
Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma FREE
M Matsumoto, M Furihata, T Ishikawa, Y Ohtsuki and S Ogoshi
Br J Cancer 80: 256-261; doi:10.1038/sj.bjc.6690348
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy FREE
L G Walker, M B Walker, K Ogston, S D Heys, A K Ah-See, I D Miller, A W Hutcheon, T K Sarkar and O Eremin
Br J Cancer 80: 262-268; doi:10.1038/sj.bjc.6690349
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial FREE
J S Waters, A Norman, D Cunningham, J H Scarffe, A Webb, P Harper, J K Joffe, M Mackean, J Mansi, M Leahy, A Hill, J Oates, S Rao, M Nicolson and T Hickish
Br J Cancer 80: 269-272; doi:10.1038/sj.bjc.6690350
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer FREE
A S Protheroe, R E Banks, M Mzimba, W H Porter, J Southgate, P N Singh, M Bosomworth, P Harnden, P H Smith, P Whelan and P J Selby
Br J Cancer 80: 273-278; doi:10.1038/sj.bjc.6690351
The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer FREE
B A Lwaleed, M Chisholm and J L Francis
Br J Cancer 80: 279-285; doi:10.1038/sj.bjc.6690352
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer FREE
J H de Witte, C G J Sweep, J G M Klijn, N Grebenschikov, H A Peters, M P Look, ThH van Tienoven, J J T M Heuvel, J Bolt-De Vries, ThJ Benraad and J A Foekens
Br J Cancer 80: 286-294; doi:10.1038/sj.bjc.6690353
Mutation testing in melanoma families: INK4A, CDK4 and INK4D FREE
J A Newton Bishop, M Harland, D C Bennett, V Bataille, A M Goldstein, M A Tucker, B A J Ponder, J Cuzick, P Selby and D T Bishop
Br J Cancer 80: 295-300; doi:10.1038/sj.bjc.6690354
Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients FREE
K Fujita, K Denda, M Yamamoto, T Matsumoto, M Fujime and T Irimura
Br J Cancer 80: 301-308; doi:10.1038/sj.bjc.6690355
Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis FREE
T Tsurusaki, S Kanda, H Sakai, H Kanetake, Y Saito, K Alitalo and T Koji
Br J Cancer 80: 309-313; doi:10.1038/sj.bjc.6690356
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
